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Environmental Factors 
in Birth Defects
What We Need to Know
Worldwide, at least 7.9 million people are born each year with a birth defect. Of the children 
affected by birth defects, at least 3.3 million die each year before age 5, and about 3.2 million of 
surviving children could be mentally or physically disabled for life. Currently the causes of only 
about 30% of birth defects are even somewhat well understood.
—Global Report on Birth Defects: The Hidden Toll of Dying and Disabled Children 
G
iven the myriad steps 
involved in fetal growth, 
each  presenting  the 
opportunity for devel-
opmental mischief, it is not surprising that 
more than 7,000 kinds of birth defects 
are known to occur. The causes of birth 
defects remain largely a mystery, however, 
although a few culprits have been identified 
as important contributors, including some 
environmental agents.
In the developing world, where malnu-
trition, poverty, disease, and lack of access 
to health care elevate prenatal risk, birth 
defects impose “enormous personal and 
societal consequences,” according to the 
2003 Institute of Medicine report Reducing 
Birth Defects: Meeting the Challenge in the 
Developing World. Experts in the developed 
world often have similar concerns, because 
in many regions birth defects are the largest 
single cause of infant deaths.A 442  v o l u m e  117 | n u m b e r  1 | January 2009  •  Environmental Health Perspectives
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But reliable numbers for both defects 
and cases remain unclear, due in large part 
to a lack of funding, coordinated monitor-
ing efforts, and adequate data. The causes of 
only about 30% of birth defects are some-
what well understood, and knowledge even 
of those is sometimes spotty. The 70% still 
unknown leaves open the possibility that 
environmental factors could play a signifi-
cant role. “There are all kinds of classifica-
tion and data challenges that are tough to 
overcome,” says Ted Schettler, science direc-
tor of the nonprofit Science and Environ-
mental Health Network. “It almost makes 
cancer tracking look easy—[those research-
ers are] getting pretty standardized data 
that’s completely not available in the world 
of birth defects.”
Defining “Defects” 
There is no universally accepted defini-
tion of what constitutes a birth defect. 
The term is sometimes limited to apparent 
structural problems, but often is expanded 
to include defects in function, metabolism, 
or body chemistry that lead to physical 
or mental problems or to death. Prema-
ture birth and low birth weight, which are 
linked with numerous health problems 
later in life, also can be influenced by birth 
defects, although factors such as young 
maternal age and poor access to medical 
care contribute as well. Birth defects also 
can be a contributing factor to some mis-
carriages and stillbirths. 
Worldwide, at least 7.9 million peo-
ple are born each year with a birth defect, 
according to Global Report on Birth Defects: 
The Hidden Toll of Dying and Disabled 
Children, a 2006 report by the March of 
Dimes Foundation, a birth defects research 
and  advocacy  group.  The  authors  say 
their report is the first to provide global, 
country-by-country data on birth defects, 
with information from more than 190 
nations. The report is especially helpful 
as a springboard for further investigation 
because 85% of the world’s birth defects 
occur in developing countries, but only 
four such countries have birth defect pro-
grams that can track occurrences, says Li 
Zhu, director of China’s National Ref-
erence Laboratory on Reproductive and 
Child Health.
Of the children affected by birth 
defects, at least 3.3 million worldwide die 
each year before age 5, according to the 
Global Report. Of those that survive, about 
3.2 million will be mentally or physically 
disabled for life, although some of these 
effects may be mitigated with appropri-
ate care. Actual numbers may be much 
higher, according to some experts, because 
they don’t account for certain functional 
and developmental birth defects, and 
because surveillance data on birth defects 
remain relatively primitive. Moreover, elec-
tive abortion after defects are detected via 
screening can mask the true incidence.
Based on the report’s estimates, birth 
defects affect about 4% of live births in 
high-income countries and about 8% 
in low-income countries, with a glob-
al average of about 6%. In the United 
States, the Centers for Disease Control 
and Prevention (CDC) estimates 3% of 
children born each year have a major 
structural birth defect that appears by the 
sixth birthday. That translates to about 
130,000 U.S. children per year, although 
other estimates put the number as high as 
325,000. These and other estimates often 
don’t include stillborn deaths, of which 
about 16% are caused by birth defects, 
according to the California Birth Defects 
Monitoring Program.
Figures from the National Center for 
Health Statistics indicate that birth defects 
cause about 20% of infant deaths in the 
United States. There are large geographi-
cal differences in the United States for 
infant death rates overall and for deaths 
attributed to birth defects. For deaths asso-
ciated with birth defects, which averaged 
0.43% of all infant deaths from 1999 to 
2005, the South and Midwest are both 
about 40% higher than the Northeast. 
These large geographic variations readily 
allow for the possibility that variations in 
environmental exposures may be playing a 
role. They also reflect differences in local 
culture, socioeconomics, health care, and 
genes (some of these factors can in turn 
influence the rate of elective abortion). 
But they likely also reflect reporting and 
data quality variations, says Craig Mason, 
president of the National Birth Defects 
Prevention Network—hence the need for 
improved surveillance systems at a time 
when such programs are being cut or risk 
being eliminated altogether.
Lorenzo Botto, an associate profes-
sor in the University of Utah Division of 
Medical Genetics, agrees, saying, “A real 
problem is lack of funding. Birth defect 
programs are being cut, even in terms of 
basic surveillance infrastructure, or funded 
just to maintain basic monitoring capacity. 
This is true in the United States [but] even 
more so in developing countries, where 
there is not much spare capacity to look at 
environmental studies.” 
Environmental Red Flags
When it comes to fetal exposures, any 
exposure that occurs by way of the mother 
typically is considered “environmental.” A 
relatively small proportion of birth defects 
can be attributed, at least in part, to specific 
environmental causes such as maternal dis-
ease (e.g., rubella) or use of pharmaceuticals 
(e.g., valproic acid, an anticonvulsant and 
mood stabilizer). However, the majority 
of birth defects are considered the result 
of multiple environmental and/or genetic 
causes acting together. Lack of sufficient 
folic acid in the diet, for example, is one 
environmental factor now being remedied 
       
T
here are all kinds of classification and 
data challenges that are tough to overcome 
[in birth defect surveillance]. It almost makes 
cancer tracking look easy.
—Ted Schettler
Science and Environmental Health Network
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with supplements and food fortification. 
Among other environmental exposures 
with some incriminating evidence are other 
nutrient imbalances, maternal smoking and 
alcohol use, pesticides, tap water disinfec-
tion by-products, plastics and plastics com-
ponents, solvents, metals, and numerous air 
pollutants (see table, p. A446). 
Pinning down the role of environ  mental 
agents  remains  a  daunting  challenge, 
however. “Of all the antecedents of birth 
defects, environmental factors are least well 
understood,” says Michael Katz, March of 
Dimes senior vice president for research and 
global programs. “This is inevitable inas-
much as there are few isolated influences. 
In most situations the environment imposes 
an avalanche of possible stimuli, some ben-
eficial, many neutral, and others possibly 
harmful. Add to this the possibility that 
interactions between two such factors—or 
more likely among many—may result in 
different effects, and you have an inkling 
of the complexity of the problem.” Officials 
from the California Birth Defects Monitor-
ing Program also point to the difficulty of 
extrapolating from animal data to human 
health effects, our lack of knowledge about 
the role of genetic factors in birth defects, 
and the lack of data on both exposures dur-
ing pregnancy and the effects of specific 
exposures on the fetus. 
Many experts are concluding that 
genetic factors are always implicated in birth 
defects. “We don’t know of any environ-
mental exposures where a hundred percent 
of kids are affected,” says Tina Chambers, a 
perinatal epidemiologist in the Division of 
Dysmorphology and Teratology at the Uni-
versity of California, San Diego. “We think 
there are gene–environment interactions 
with all these [cases].” However, even with 
the many environmental red flags that have 
been raised so far, the field of investigation 
remains vast. “We really don’t know the 
right questions to ask,” Chambers says. 
Crawling Toward a New Path
There’s no shortage of ideas on ways to 
improve our understanding of birth defects 
and the role of the environment. Stuart 
Newman, a professor of cell biology and 
anatomy at New York Medical College, 
is in the camp of those recommending 
major shifts in thinking. He would like 
to see birth defects as a whole addressed 
at multiple levels from the micro to the 
macro. “It will take a more integrated and 
holistic approach,” he says. His preference 
is to meld the fields of genetics, develop-
mental biology, evolutionary developmen-
tal biology, environmental science, and 
sociology—fields that often have a near or 
total disconnect among them—although 
he acknowledges there aren’t yet good 
models for how to do this. 
Betty Mekdeci, executive director of 
the advocacy group Birth Defect Research 
for Children, says there are many problems 
with the basics of how birth defects are 
tracked and evaluated. Her experience of 
more than 30 years—prompted by her 
efforts, and those of her husband, to figure 
out why their son was born with multiple 
birth defects—led her to conclude that 
some of the most important limitations 
include inadequate medical diagnostic 
codes for classifying many birth defects, 
inaccurate use of codes by health care prac-
titioners to meet insurance billing require-
ments, and the inability of many health 
care practitioners to diagnose a birth defect 
at birth or in follow-up visits, and skep-
ticism toward the input of parents, who 
usually know better than any one doctor 
about the full range of health problems 
their child is having.
To overcome some of these problems, 
Mekdeci and her colleagues have developed 
an alternative method of tracking birth 
defect incidence based on parent responses 
to a lengthy questionnaire. About 6,000 
completed questionnaires have been col-
lected since 1990. Mekdeci and her staff 
analyze the questionnaire responses for pat-
terns, and she reports they have identified 
about half a dozen clusters so far. Although 
the group readily acknowledges these are 
self-reports from a self-selected population, 
some of the clusters have later been con-
firmed by various government agencies. 
For instance, in Dickson, Tennessee, they 
detected a cleft palate cluster that was con-
firmed by the CDC. The group sees its role 
as identifying birth defect cases and then 
encouraging health agencies to investigate.
Assuming the current modes of think-
ing and operating continue for a while, 
Schettler says better use of existing infor-
mation and resources can still be very 
beneficial. “We should be doing some 
cross-agency work to better simulate [expo-
sures in] the world we live in,” he says. “It’s 
sort of a failure of our [research] system to 
not think out of our silos.” As one example 
of such failures, he cites evidence based on 
animal studies that the teratogenic action 
of valproic acid is exacerbated with concur-
rent zinc deficiency and reduced with zinc 
supplementation. Because zinc deficiency 
affects an estimated 25–40% of the gen-
eral population worldwide, according to a 
report by Wolfgang Maret and Harold H. 
Sandstead in the 10 May 2006 Journal of 
Trace Elements in Medicine and Biology, this 
interaction may be very important to public 
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n most situations the environment imposes an avalanche of 
possible stimuli, some beneficial, many neutral, and others 
possibly harmful. Add to this the possibility that interactions 
between two such factors—or more likely among many— 
may result in different effects, and you have an inkling of the 
complexity of the problem.
—Michael Katz
March of Dimes Foundation
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health, he says. However, it has rarely been 
studied in humans. 
Put another way, says Helen Dolk, proj-
ect leader for EUROCAT (European Sur-
veillance of Congenital Anomalies), “On the 
one hand we act too little on the environ-
mental causes we know about, and on the 
other hand we do too little research to find 
out more about the environmental causes.” 
However, Dolk points out, “There is 
surveillance, and there is research, and 
there is a spectrum between the two. We 
need specifically designed research—
this  does  not  need  to  be  nationwide, 
but components of it will need very big 
population numbers, as birth defects are 
relatively rare. Research will be largely 
hypothesis-testing. . . . We also need sur-
veillance, or tracking, which will throw 
up areas of concern and is more fre  quently 
hypothesis-generating. Putting all our 
Birth Defect Rates Around the World, 2001
More than 69.9 birth 
defects per 1,000 live 
births.
61–69.9 birth defects 
per 1,000 live births.
52.1–60.9 birth defects
per 1,000 live births.
Fewer than 52.1 birth 
defects per 1,000 live 
births.
No data.
Birth defects are particularly prevalent in middle- and 
low-income countries. Besides poverty, the main reasons 
for the variations among higher- and lower-income coun-
tries in birth prevalence rates of serious birth defects 
include
survival advantage against malaria for carriers of  •	
sickle cell and thalassemia genes,
frequency of consanguineous (blood relative)  •	
marriages,
differences in the percentage of older mothers, and •	
disparities in maternal and child health services. •	
Countries have been grouped by gross national income 
(GNI) per capita:
Low-income countries have a GNI per capita  •	
per year of less than $826 and accounted for an 
estimated 4.75 million serious birth defects in 2001, 
60.2% of the world’s total.
  Middle-income countries have a GNI per capita  •	
per year of $826–$10,065 and accounted for 
an estimated 2.67 million serious birth defects, 
33.5% of the world’s total. 
  High-income countries have a GNI per capita per  •	
year of more than $10,065 and accounted for an 
estimated 500,000 serious birth defects, 6.3% of 
the world’s total.
Source: March of Dimes Foundationresources in one of these areas without the 
other will not achieve the results we need.”
Moreover, she adds, “Funding often 
follows ‘fashions’ and dogma, and we need 
a balanced approach, judging case–control, 
cohort, and other studies on their own mer-
its, rather than completely turning from 
one type to another.”
Priorities for Change
Even if none of the recommended shifts in 
overall approach occur, other major adjust-
ments are needed before much more progress 
can occur, says Christopher Howson, vice 
president for global programs at the March 
of Dimes. Paramount among these is more 
leadership and guidance from the World 
Health Organization (WHO). “The WHO 
is a very important player in international 
health,” Howson says. “To get the impri-
matur of the WHO gives health ministers 
the authority they need to address [specific 
health] issues.” 
The WHO has addressed birth defects 
to some extent, but the issue “has not been 
on the priority list of the WHO agenda yet,” 
Zhu says. Dolk adds, “The WHO needs to 
incorporate prevention of birth defects into 
programs to tackle major health determi-
nants and improve maternal and reproduc-
tive health, recognizing the importance of 
environmental causes of birth defects.”
Howson says it’s critical to have individ-
ual countries establish a consistent national 
policy and approach for certain key ele-
ments, including the birth defects covered 
and the identification and tracking methods 
used. Within such a framework, he recom-
mends designating a point person in one fed-
eral agency in each country as having central 
responsibility. That official would coordi-
nate with representatives from other agencies 
to orchestrate consistency of identification, 
tracking, and reporting methods; agreement 
on what birth defects to track; and even 
basic logistical elements such as ensuring 
that software packages used are compatible 
with various computer systems. With that 
kind of structure in place, he would like to 
see all health-related programs in a country 
incorporate relevant birth defect information 
into their work, whether it’s related to nutri-
tion, disease, pollutants, genetics, or other 
fields. He also would like to see the WHO 
and individual countries develop extensive 
education programs to inform both citizens 
and health professionals about birth defects, 
known causes and remedies, and other basic 
information.
Dolk raises another issue—that of data 
confidentiality and parental consent for 
babies with birth defects to be included in 
surveillance systems. “Experience shows that 
most parents do not refuse [to participate] 
and even expect this for the good of future 
babies,” she says. “However, requirements to 
obtain consent can be logistically very diffi-
cult and costly to implement—in a number 
of European countries this problem has not 
been solved adequately to allow data to be 
fully used.”
In still another arena, experts are split 
to some degree on whether a centralized 
national health system, in which everyone’s 
comprehensive health records are accessible 
from one source, is necessary for robust sur-
veillance. Dolk says, “Experience has gener-
ally been that centralized national systems 
result in poor data compared to decentral-
ized systems closer to those producing and 
using the data.” However, she adds, this 
depends on the size of the country and on 
the types of information systems avail-
able for use and linkage. “Thus,” she says, 
“national Scandinavian systems work well.”
Norway and Denmark have extensive 
data for just about everyone in the country, 
including health records, socioeconomic and 
occupational information, and other demo-
graphics. “These countries have been able 
to do some very cool linkage studies,” says 
Andrew Olshan, chairman of the Depart-
ment of Epidemiology at the University of 
North Carolina at Chapel Hill. Some of 
those studies have been conducted through 
the Norwegian Mother and Child Cohort 
Study and the Danish National Birth 
Cohort Study. Each study is evaluating 
about 100,000 women and their children 
over the course of at least 15–20 years for 
a wide range of factors, including selected 
birth defects. However, evaluation of any 
links between birth defects and environ-
mental exposures is likely to be limited due 
to constraints on the quality and availability 
of data for specific toxic exposures.
Margaret Honein, Birth Defects Branch 
chief in the CDC’s National Center on Birth 
Defects and Developmental Disabilities, 
believes a decentralized approach also can 
work. “I think what’s needed is to make 
sure it’s possible to do good surveillance, 
with nothing obstructing [state programs],” 
she says. “What’s most important is to get 
high-quality data from all the programs.” 
However, in the United States, about 10% of 
states don’t even have a birth defects registry, 
about 20% have very limited data, and the 
remaining 70% have data that often can’t be 
compared state-to-state, according to “Pop-
ulation-Based Birth Defects Surveillance 
Data from Selected States, 2001–2005,” a 
CDC report that constitutes the December 
2008 issue of Birth Defects Research: Part A: 
Clinical and Molecular Teratology. 
Even more limiting, from an environ-
mental perspective, is that two-thirds of 
U.S. states don’t explore any links between 
birth defects and environmental exposures, 
according to a 2005 report from the health 
advocacy group Trust for America’s Health 
titled Birth Defects and Developmental Dis-
abilities: The Search for Causes and Cures. 
The number of states that track such links 
in at least some way may be slightly higher 
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T
here is surveillance, and there is research, and 
there is a spectrum between the two. . . . Putting 
all our resources in one of these areas without the 
other will not achieve the results we need.
—Helen Dolk
European Surveillance of Congenital Anomalies
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A Sampling of Environmental Agents Studied in Relation to Birth Defects 
This list is not a comprehensive catalog of all environmental agents studied in relation to birth defects, nor should it be construed to mean 
that all the agents listed below have been established as risk factors for birth defects. The strength of evidence varies widely for each of the 
agent/birth defect associations listed below. Associations were studied in humans except where noted.
1Several diseases or their agents have links with various birth defects, including influenza, diabetes mellitus, phenylketonuria, myotonic 
dystrophy, myasthenia gravis, syphilis, Coxsackie virus B, cytomegalovirus, rubella, toxoplasmosis, and varicella zoster virus.
2High maternal temperature, whether caused by disease, sauna, or other factors, can cause birth defects.
3Numerous other pharmaceutical agents have been studied in relation to various birth defects.
Agent1,2 Birth Defect(s)
Accutane3 Head, facial, cardiac, neurologic, thymus defects
Alcohol Cardiac defects, oral clefts, fetal alcohol syndrome, cryptorchidism
Arsenic Cardiac defects
Benzene Cardiac, neural tube defects
Bisphenol A Female reproductive defects
Botulinum type A toxin3 Hearing, vision defects
Brominated flame retardants Genitourinary defects
Caffeine Cardiovascular defects, altered protein function, increased body fat (mice)
Carbon monoxide Cardiac, neurologic defects (rats)
Chlorophenoxy herbicides Cardiovascular, musculoskeletal, respiratory, skin defects
Chlorpyrifos Cardiac, facial, genitourinary, musculoskeletal, neurologic defects
Diclofop-methyl Hypospadias
Diethylstilbestrol3 Reproductive defects, cryptorchidism
Dioxins Neural tube, neurobehavioral defects; hypospadias; oral clefts
Disinfection by-products in tap water Cardiovascular, esophageal, neural tube, urogenital defects; oral clefts; gastroschisis
Ethinylestradiol3 Increased pain sensitivity (rats)
Fumonisin Neural tube defects
Glyphosate Neurobehavioral defects
Ionizing radiation Cardiac, neurologic, neural tube, skeletal defects; gastroschisis
Lead Cardiac, neural tube, neurobehavioral defects; oral clefts
Mercury Neurologic, hearing, vision defects
Methotrexate3 Skeletal defects
Methoxychlor Increased pain sensitivity (rats)
Organic solvents Neural tube, cardiac, limb defects; oral clefts; gastroschisis; developmental disorders
Organochlorine pesticides Cryptorchidism, hypospadias
Ozone Cardiac defects, cleft lip with or without cleft palate
Particulate matter Vascular defects (patent ductus arteriosus)
Polychlorinated biphenyls Hearing defects (rats)
Perfluorooctane sulfonate  Cleft palate (mice)
Phosphine Neurologic, neurobehavioral defects
Phthalates Male reproductive defects
Polycyclic aromatic hydrocarbons Neurodevelopmental defects
Secondhand tobacco smoke Neurobehavioral, cardiac, limb, respiratory defects; oral clefts; hypospadias; gastroschisis
Sulfur dioxide Musculoskeletal, cardiac defects (cattle)
Thalidomide3 Limb defects
Trichloroethylene Neural tube defects, oral clefts
Valproic acid3 Neural tube defects           
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now, says Mason, although he reiterates 
that recent economic problems are causing 
some states to cut back on their birth defect 
programs.
Time for a Parade?
The National Children’s Study (NCS), just 
getting under way in the United States, is 
expected to include extensive data on the 
effect of environmental exposures on fetal 
and child health. The NCS offers the best 
chance in the near term of improving our 
knowledge of links between environmen-
tal factors and birth defects, according to 
Chambers. 
Most birth defects research to date has 
been conducted retrospectively, relying on 
recall of study participants of events often 
occurring many years earlier, and lacking 
data on actual specific exposures of partici-
pants. In contrast, the NCS aims to enroll 
100,000 women from representative popula-
tions and follow their children from concep-
tion through age 21. The NCS will collect 
biological samples from parents and children 
as well as samples of air, drinking water, 
interior dust, and soils from participants’ 
homes. These will be stored along with all 
medical records, giving future researchers 
the ability to evaluate a wide range of struc-
tural, functional, and developmental birth 
defects, says NCS acting director Steven 
Hirschfeld—even though we may not have 
the insights or tools to know what to look 
for or how to look for it today. 
Chambers, who is a principal investiga-
tor in the study, says early results should 
begin to trickle out in about five years; data 
on birth defects that show up soon after 
birth will be among the first available for 
each participant. 
Even  more  statistical  power  could 
someday be available by combining study 
resources. A prototype for such research is 
the International Childhood Cancer Cohort 
Consortium (I4C), which is just beginning 
to analyze its first batches of data. The I4C 
project is an ambitious effort to facilitate 
apples-to-apples comparisons among mul-
tiple studies for specific end points. The ini-
tial focus is on childhood leukemia, which 
has been linked for many years with Down 
syndrome. In a review published in the Feb-
ruary 2009 issue of The Oncologist, Karen 
R. Rabin and James A. Whitlock note that 
children with Down syndrome have a 10- to 
20-fold higher risk of some form of child-
hood leukemia, although studies of potential 
environmental factors connecting the two 
conditions have been inconclusive. How-
ever, recent research is showing that the rela-
tionship between childhood leukemia and 
genetic abnormalities present at birth may 
extend further, says Carol Kasten, a geneticist 
at the U.S. National Cancer Institute—and 
I4C is expected to provide more insights.
The initial I4C group, whose first work-
shop was held in 2005, included 11 cohorts 
from 9 countries. Some of these studies 
were already well under way, others only just 
starting. Among those with higher numbers 
of participants are the NCS in the United 
States, the Danish and Norwegian studies, 
and studies in China and Israel. Others have 
far fewer participants, sometimes just a few 
thousand. But all combined, I4C includes 
about 700,000 mothers, and at least some 
of the cohorts will be able to provide data 
on environmental factors such as pesticides, 
tobacco smoke, and electromagnetic fields. 
Research projects from other countries 
that have been invited to attend a November 
2009 I4C conference in Lyon, France, may 
also join the group. These include projects in 
Brazil, Canada, Japan, the European Union, 
South Korea, and South Africa. A second 
Chinese program (in addition to the study 
already participating in I4C) currently in its 
pilot phase could add hundreds of thousands 
more mothers.
If the I4C program works as expected, 
it could bode well for birth defects research. 
“I’m sure we’ll get to birth defects at some 
point with I4C,” Kasten says. A similar pro-
gram focusing specifically on birth defects 
of all types doesn’t exist yet, Kasten says, 
“but certainly people are wondering, ‘Why 
don’t we do that?’” 
In addition to these efforts, a few studies 
of links between certain birth defects and 
environmental agents have been conducted 
using data from some of the 43 registries 
in 20 countries that participate in EURO-
CAT. This network of European popu-
lation-based registries began in 1979 and 
today includes about 30% of the European 
birth population. A parallel compilation of 
continent-wide data has occurred since 1974 
through the Latin American Collaborative 
Study of Congenital Malformations. This 
study focuses on genetics, pharmaceuticals, 
alcohol, smoking, nutrition, and maternal 
disease, but links to pollutants are studied 
extremely rarely. The International Clear-
inghouse for Birth Defects Surveillance 
and Research, also operating since 1974, 
provides a forum for collaboration among 
countries from around the world. It does not 
itself offer a specific mechanism for tracking 
impacts of specific environmental agents, 
but some of its members do conduct such 
research. 
Still more information on environmental 
links to birth defects may come from the 
Metropolitan Atlanta Congenital Defects 
Program, one of the oldest such programs in 
the world, operating since 1967. It is limited 
in geographic coverage, including residents 
of just five central-Atlanta counties, but it 
conducts active surveillance of major struc-
tural birth defects through doctors’ offices, 
clinics, and genetic laboratories rather than 
relying on hospital birth records, which is a 
limitation of some registries. Whereas many 
registries stop at birth or after the first year 
of life, the Atlanta program follows children 
up to their sixth birthday, which is impor-
tant because some defects are not associated 
with any symptoms until the child is older. 
Honein says a few projects involving envi-
ronmental substances (which she declined 
to name) are in the early stages, and results 
from initial studies may be available within 
a year or so.
In addition to the Atlanta program, 
four of the nine CDC-supported Centers 
for Birth Defects Research and Prevention 
may soon begin to publish a few insights 
related to various environmental exposures, 
Honein says. These centers are participat-
ing in the National Birth Defects Preven-
tion Study, the largest etiologic study of its 
type ever conducted. Each year, each center 
identifies approximately 300 new mothers 
of children with common birth defects as 
well as 100 control mothers. Doctors and 
researchers review each case in detail, look-
ing for known or suspected factors. Various 
centers are studying agricultural pesticides, 
disinfection by-products, and hazardous 
waste emissions, among other exposures. 
The study began in 1997, and the database 
now includes about 25,000 births. In addi-
tion, CDC officials are in the early stages of 
considering studies of additional air, water, 
and soil pollutants and utilizing other envi-
ronmental data, Honein says.
Other efforts that may generate informa-
tion related to environmental exposures are 
expected to trickle out via other independent 
and government agency research around the 
world. But although these efforts to improve 
information about environmental and other 
causes of birth defects offer some potential 
for expanded knowledge, the broader-scale 
limitations of making significant advances, 
including a perennial lack of funding, leave 
some critics skeptical. 
Others are more optimistic, however. 
Howson sees the progress made so far, and 
the groundwork that has been laid for future 
progress, as something akin to a favorite 
children’s activity: “It’s like a kid going out 
into the street to bang his drum. Another 
kid joins him, then another and another. By 
the end of the street, you have a parade.”
Bob Weinhold, MA, has covered environmental health 
issues for numerous outlets since 1996. He is a member of 
the Society of Environmental Journalists.